Related Experiment Video
Updated: Sep 9, 2025

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
Published on: July 1, 2020
Genome-Wide Pleiotropy Analysis Identifies Shared and Opposing Pathways Influencing Coronary Artery Disease and
James Yarmolinsky1, Evelyn Lau2, Fotios Koskeridis1
1Department of Epidemiology and Biostatistics, School of Public Health (J.Y., F.K., M.J.G., A.D., I.T.), Imperial College London, United Kingdom.
Background:
Coronary artery disease (CAD) and cancer are 2 leading global causes of mortality, with shared modifiable risk factors, yet the genetic and molecular mechanisms underlying their comorbidity remain poorly understood.
Methods:
We performed a genome-wide pleiotropy analysis to identify shared genetic mechanisms across CAD and 4 common cancers that share modifiable risk factors with CAD (breast, colorectal, lung, prostate).
Results:
Using genome-wide pleiotropy and colocalization analysis, we identified 60 colocalized susceptibility loci shared by CAD and site-specific cancer, of which 43 are novel, including loci at TERT, MYO9B, and SREBF1. For 35 loci, the lead SNP (single-nucleotide polymorphism) exhibited opposing effects on CAD and cancer risk. Gene-set enrichment analysis revealed distinct enrichment patterns of same-direction and opposing-direction pleiotropic loci, including differential associations with blood pressure-related traits, blood cell traits, and waist circumference. By integrating transcriptomic and proteomic data in multitrait colocalization, 13 pleiotropic loci influenced CAD and cancer risk via differential gene or protein expression of neighboring genes, including CALCRL, ANGPTL4, and LAMC1, targets of approved or investigational medications. Phenome-wide association analysis in the UK Biobank identified 1955 associations (false discovery rate [FDR] P<0.05) of lead SNPs at multitrait colocalized loci with serum biomarkers and clinical measures, with apoA, HDL (high-density lipoprotein) cholesterol, and creatinine being associated with the largest number of lead SNPs.
Conclusions:
Our findings highlight shared and opposing genetic loci between CAD and cancer and provide insight into molecular intermediates mediating joint disease risk. Importantly, they indicate potential drug repurposing opportunities for dual CAD and cancer prevention while highlighting possible adverse and divergent effects of existing medications across both conditions.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pleiotropy
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Coronary Artery Disease II: Pathophysiology
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Single Nucleotide Polymorphisms-SNPs